The Hydroxylase Inhibitor Dimethyloxalylglycine Is Protective in a Murine Model of Colitis

Eoin P. Cummins(University College Dublin), Fergal Seeballuck(Sigmoid Pharma (Ireland)), Stephen J. Keely(Royal College of Surgeons in Ireland), Niamh E. Mangan(St. James's Hospital), John J. Callanan(University College Dublin), Padraic G. Fallon(Trinity College Dublin), Cormac T. Taylor(University College Dublin)
Gastroenterology
October 11, 2007
10.1053/j.gastro.2007.10.012
Cited by 405Open Access
Full Text

Abstract

Related Papers

Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Peter Carmeliet, Yuval Dor, Jean-Marc Herbert et al.|Nature|1998|2.5k
A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice
Isao Okayasu, Shigeru Hatakeyama, Masahiro Yamada et al.|Gastroenterology|1990|2.4k
Clinicopathologic study of dextran sulfate sodium experimental acute colitis
Kazuko Shichijo, Mutsumi Matuu, Yuji Ikeda et al.|The Japanese Journal of Pharmacology|1998|1.9k
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
David Lando, Daniel J. Peet, Dean A. Whelan et al.|Science|2002|1.5k
The fundamental basis of inflammatory bowel disease
Warren Strober, Ivan J. Fuss, Peter Mannon|Journal of Clinical Investigation|2007|1.3k